Goldenwell Biotech, Inc.
GWLL
$0.20
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.50% | -17.41% | -12.10% | 87.66% | 86.03% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 121.05% | 250.00% | 740.00% | -- | -- |
| Change in Net Operating Assets | 6,855.56% | -77.78% | -96.30% | -86.54% | -96.37% |
| Cash from Operations | 88.48% | -10.98% | -5.22% | 88.23% | 86.35% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -57.55% | 3.20% | -18.06% | 68.63% | 229.80% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 83.33% | 83.33% | 83.33% | -- | -- |
| Cash from Financing | -53.60% | 24.43% | -2.66% | -88.20% | -84.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 489.53% | 63.64% | -153.42% | 84.38% | 133.46% |